SQZ Biotechnologies Company IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| SQZ Biotechnologies Company | SQZ - NYSE |
$16.00-$18.00 | $16.00 | $15.05 | 4.4 million | 10/30/2020 |
| BofA Securities, Stifel | ||||||
Co-Manager(s): BTIG | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-10-09 Terms Added 2020-10-26 | ||||||
SQZ Biotechnologies Company Quote & Chart - Click for current quote - SQZ
IPO Boutique aggregates information on public companies and private companies, such as "SQZ" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About SQZ Biotechnologies Company (adapted from SQZ Biotechnologies Company prospectus):
They are a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases and other serious conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases and other serious conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "SQZ" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.